• Tetracycline in Translational Research: Mechanistic Power an

  2026-05-26

  Explore how Tetracycline, a broad-spectrum polyketide antibiotic, empowers translational researchers not only as a staple antibiotic selection marker but also as a mechanistic probe for ribosomal and membrane biology. This thought-leadership article synthesizes recent advances in understanding bacterial protein synthesis inhibition, contextualizes findings from emerging fibrosis and ER stress models, and provides strategic guidance for maximizing experimental and translational impact.

• Berberrubine Chloride: Precision Chemosensitization in NSCLC

  2026-05-26

  Explore how Berberrubine chloride, a multi-target isoquinoline alkaloid, selectively enhances chemosensitivity in cancer research. This article delivers new assay insights and mechanistic clarity, setting it apart from existing resources.

• Wnt Agonist 1 (BML-284): Applied Workflows & Troubleshooting

  2026-05-25

  Wnt agonist 1 (BML-284) enables precise, reproducible activation of canonical Wnt signaling for advanced cellular differentiation and chemoresistance studies. Explore robust protocols, troubleshooting strategies, and experimental enhancements grounded in recent translational research.

• Gastrin I (human): Advancing Translational GI Research Model

  2026-05-25

  Explore how human Gastrin I peptide enables mechanistic and translational breakthroughs in gastrointestinal research. This article integrates cutting-edge organoid models, mechanistic insight, and actionable guidance for researchers aiming to bridge discovery with clinical impact.

• TCAIM Modulates Mitochondrial Metabolism via OGDH Regulation

  2026-05-24

  This study by Wang et al. uncovers a unique role for the mitochondrial DNAJC co-chaperone TCAIM in selectively reducing a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating mitochondrial metabolism. The work reveals a non-canonical, post-translational regulatory pathway with implications for cellular metabolism research and the understanding of mitochondrial proteostasis.

• PLK1 Regulates Gut Homeostasis and Molting in Locusta migrat

  2026-05-23

  This study provides the first molecular and functional characterization of the Polo-Like Kinase 1 (PLK1) gene in the migratory locust, revealing its essential roles in midgut homeostasis, molting, and susceptibility to insecticides. The findings identify LmPLK1 as a promising target for RNAi-based pest management and illuminate new mechanisms underlying insect development.

• Protoporphyrin IX: From Heme Synthesis to Ferroptosis Innova

  2026-05-22

  This thought-leadership article explores Protoporphyrin IX as a pivotal photodynamic compound at the crossroads of heme biosynthesis, iron metabolism, and translational cancer research. By blending mechanistic insight with strategic workflow guidance, it reveals how this molecule underpins advances in ferroptosis resistance studies, photodynamic cancer diagnosis, and therapeutic innovation—while highlighting APExBIO’s leadership in supplying high-purity Protoporphyrin IX for next-generation research.

• NPT1 as a Renal Apical Transporter for Organic Anions and Pe

  2026-05-22

  This study identifies human NPT1 as the key transporter mediating p-aminohippuric acid (PAH) and select β-lactam antibiotics, including faropenem, across the renal apical membrane. The findings elucidate substrate specificity and transport dynamics crucial for pharmacokinetic studies of penem antibiotics, informing both basic research and translational workflows.

• Tin Mesoporphyrin IX (chloride): Mechanistic Insights and Ne

  2026-05-21

  Explore the mechanistic depth and translational potential of Tin Mesoporphyrin IX (chloride) as a potent inhibitor of heme oxygenase. This article delivers advanced technical detail and cross-domain context not found in existing literature.

• Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP)

  2026-05-21

  EZ Cap™ Human PTEN mRNA (ψUTP) offers reliable, immune-evasive PTEN restoration for cancer research, leveraging enhanced mRNA stability and translational efficiency. This guide details optimized protocols, advanced use-cases, and troubleshooting strategies, translating the latest nanoparticle-mediated delivery breakthroughs into actionable laboratory workflows.

• Pam3CSK4 TFA: Synthetic TLR1/2 Agonist for Innate Immunity

  2026-05-20

  Pam3CSK4 TFA is a synthetic TLR1/2 agonist used to activate innate immune responses in vitro and in vivo. It enables precise dissection of TLR1/2-driven cytokine pathways, including IL-17A, making it essential for research in inflammation and maternal-neonatal immunity. High purity and reproducible activity are validated by both product specifications and peer-reviewed studies.

• Caveolin-1 Regulates Cholesterol Homeostasis in MASLD Progre

  2026-05-20

  This study demonstrates that Caveolin-1 (CAV1) mitigates the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) by restoring cholesterol balance, reducing endoplasmic reticulum (ER) stress, and suppressing pyroptosis. The findings provide mechanistic insight into how CAV1 influences hepatic cholesterol trafficking and inflammatory cell death, offering valuable directions for MASLD research and potential therapeutic intervention.

• Rotigotine: Dopamine D2/D3 Receptor Agonist in PD Research

  2026-05-19

  Rotigotine stands out as a versatile dopamine D2/D3 receptor agonist, enabling robust modeling of Parkinson’s disease and neuroprotection workflows. This article bridges recent nanoparticle innovations with actionable in vitro and in vivo protocols, offering troubleshooting advice and comparative insights for translational neuroscience research.

• CX-5461: Advanced Mechanistic Insights and Decision-Making i

  2026-05-19

  Discover how CX-5461, a potent RNA polymerase I inhibitor, enables selective inhibition of ribosome biogenesis and drives advanced cancer research strategies. This article delivers nuanced, evidence-driven guidance for protocol optimization and experimental interpretation.

• Moesin as a Biomarker of Endothelial Injury in Sepsis Models

  2026-05-18

  This study identifies moesin as a novel biomarker of endothelial injury in sepsis, demonstrating its correlation with disease severity and its mechanistic role in vascular dysfunction via the Rock1/MLC and NF-κB pathways. These insights offer a foundation for improved diagnostic and research approaches into sepsis-related endothelial pathology.

15560 records 1/1038 page Next 12345 下5页 Last page